SCHEDULE 13GAccepted Sep 30, 6:35 PM ET
Indivior Pharmaceuticals, Inc. SCHEDULE 13G
Accepted (ET)
6:35 PM
Sep 30, 2026
Filed
Sep 30, 2026
Documents
2
Size
15.9 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.